<DOC>
	<DOC>NCT00259012</DOC>
	<brief_summary>The purpose of this study is to characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profiles to determine the safety and tolerability of single and multiple doses of pantoprazole in infants aged 1 through 11 months.</brief_summary>
	<brief_title>Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Greater than 44 weeks beyond neonatal period but less than 12 months Presumptive diagnosis of GERD Weight greater than 2.5 kg but less than 15 kg History of gastrointestinal (GI) disorders, ie, unrepaired tracheal esophageal fistula, GI malabsorption Clinically significant medical or surgical abnormalities</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>11 Months</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>GERD</keyword>
	<keyword>Infant</keyword>
</DOC>